OBJECTIVES: To evaluate the value of combined use of survivin, cytokeratin (CK) 20 and mucin (MUC) 7 mRNA in comparison with voided urine cytology in the detection of bladder cancer patients. METHODS: One hundred and fifty three patients and 20 healthy volunteers were evaluated by RT-PCR for detecting survivin, CK-20 and MUC7 mRNA in voided urine before cystoscopy. The three markers and cytology were evaluated independently or in combinations. RESULTS: The overall sensitivity and specificity were 90.4 and 94.7% for survivin, 82.6 and 97.4% for CK-20, 62.6 and 94.7% for MUC7 and 46.0 and 100% for voided urine cytology. Combined sensitivity of voided urine cytology with the three biomarkers together was higher than either combined sensitivity of voided urine cytology with one of the biomarkers or than that of the biomarker alone. CONCLUSIONS: Combined use of the three markers can improve the sensitivity for detecting bladder cancer.
OBJECTIVES: To evaluate the value of combined use of survivin, cytokeratin (CK) 20 and mucin (MUC) 7 mRNA in comparison with voided urine cytology in the detection of bladder cancerpatients. METHODS: One hundred and fifty three patients and 20 healthy volunteers were evaluated by RT-PCR for detecting survivin, CK-20 and MUC7 mRNA in voided urine before cystoscopy. The three markers and cytology were evaluated independently or in combinations. RESULTS: The overall sensitivity and specificity were 90.4 and 94.7% for survivin, 82.6 and 97.4% for CK-20, 62.6 and 94.7% for MUC7 and 46.0 and 100% for voided urine cytology. Combined sensitivity of voided urine cytology with the three biomarkers together was higher than either combined sensitivity of voided urine cytology with one of the biomarkers or than that of the biomarker alone. CONCLUSIONS: Combined use of the three markers can improve the sensitivity for detecting bladder cancer.
Authors: Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun Journal: CA Cancer J Clin Date: 2005 Jan-Feb Impact factor: 508.702
Authors: Sanaa Eissa; Gamal Kenawy; Menha Swellam; Amal Abou El-Fadle; Abdullah Ahmed Abd El-Aal; Omar El-Ahmady Journal: Clin Biochem Date: 2004-09 Impact factor: 3.281
Authors: R H Getzenberg; B R Konety; T A Oeler; M M Quigley; A Hakam; M J Becich; R R Bahnson Journal: Cancer Res Date: 1996-04-01 Impact factor: 12.701
Authors: Karsten Salomo; Doreen Huebner; Manja U Boehme; Alexander Herr; Werner Brabetz; Ulrike Heberling; Oliver W Hakenberg; Daniela Jahn; Marc-Oliver Grimm; Daniel Steinbach; Marcus Horstmann; Michael Froehner; Manfred P Wirth; Susanne Fuessel Journal: J Cancer Res Clin Oncol Date: 2017-05-08 Impact factor: 4.553
Authors: Juliane Schmidt; Catharina Propping; Woei-Yun Siow; Andrea Lohse-Fischer; Marieta Toma; Anka Baldauf-Twelker; Oliver W Hakenberg; Manfred P Wirth; Susanne Fuessel Journal: J Cancer Res Clin Oncol Date: 2015-09-02 Impact factor: 4.553